Palatin Technologies
PTN
#9820
Rank
ยฃ35.18 M
Marketcap
ยฃ20.66
Share price
28.62%
Change (1 day)
2,795.03%
Change (1 year)

Market capitalization of Palatin Technologies (PTN)

Market cap: ยฃ35.18 Million

As of December 2025 Palatin Technologies has a market cap of ยฃ35.18 Million. This makes Palatin Technologies the world's 9820th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Palatin Technologies from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ35.18 M69.58%
2024ยฃ20.74 M-51.65%
2023ยฃ42.91 M95.87%
2022ยฃ21.9 M-75.01%
2021ยฃ87.68 M-23.12%
2020ยฃ0.11 B-16.57%
2019ยฃ0.13 B20.63%
2018ยฃ0.11 B-6.3%
2017ยฃ0.12 B121.44%
2016ยฃ54.61 M79.18%
2015ยฃ30.48 M56.5%
2014ยฃ19.47 M11.68%
2013ยฃ17.43 M20.64%
2012ยฃ14.45 M60.19%
2011ยฃ9.02 M-12.95%
2010ยฃ10.36 M-52.81%
2009ยฃ21.96 M313.29%
2008ยฃ5.31 M-38.03%
2007ยฃ8.57 M-88.43%
2006ยฃ74.13 M-33.62%
2005ยฃ0.11 B49.19%
2004ยฃ74.84 M17.94%
2003ยฃ63.46 M81.29%
2002ยฃ35 M-24.97%
2001ยฃ46.65 M89.88%
2000ยฃ24.57 M116.25%
1999ยฃ11.36 M-10.61%
1998ยฃ12.71 M16.07%
1997ยฃ10.95 M642.83%
1996ยฃ1.47 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Palatin Technologies was reported to be:

ยฃ35.12 Million
by Nasdaq info icon info icon
ยฃ35.18 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MediciNova
MNOV
ยฃ56.75 M 61.31%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
ยฃ7.61 M-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ11.61 B 32,909.83%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ1.37 B 3,817.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ2.74 B 7,711.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.23 B 6,259.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ362.00 B 1,028,789.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
ยฃ1.05 B 2,909.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ209.26 B 594,670.91%๐Ÿ‡ฌ๐Ÿ‡ง UK